Oxurion NV

Oxurion nv email format

Verified email-pattern data for Oxurion Nv is currently limited. You can still use the company insights and contact sections below.
Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeutic for the treatment of DME. THR-149 is a potent plasma kallikrein inhibitor being developed as a potential new standard of care for the up to 50% of DME patients showing suboptimal response to anti-VEGF therapy. Oxurion is headquartered in Leuven, Belgium, with corporate operations in Boston, MA. More information is available at www.oxurion.com.

Company Details

Employees
35
Address
Gaston Geenslaan 1, Leuven,3001,belgium
Industry
Biotechnology Research
HQ
Leuven
Looking for a particular Oxurion NV employee's phone or email?

Oxurion Nv Questions

Explore related pages

Related company profiles:

Top Oxurion NV Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant